Treatment of the Diabetic Heart Failure Patient
Published: 01 July 2020
-
Views:
53 -
Likes:
7
-
Views:
53 -
Likes:
7
Overview
Prof Mark Petrie (University of Glasgow, Glasgow, UK) joins Dr Mikhail N Kosiborod (Saint Luke's Mid America Heart Institute, Kansas City, US) to discuss heart failure in patients with diabetes with consideration to new data emerging from SGLT2 inhibitors and GLP-1 Receptor Agonists.
More from this programme
Part 1
Diabetes and Heart Failure Outcomes
1 session | |
Diabetes and Heart Failure Outcomes | Watch now |
Part 2
SGLT2 Inhibitors in Heart Failure
1 session | |
SGLT2 Inhibitors in Heart Failure | Watch now |
Part 3
GLP-1 Receptor Agonists in Heart Failure
Faculty Biographies
Mikhail Kosiborod
Cardiologist
Dr Kosiborod is an internationally recognised expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes, and quality care and outcomes.
Mark Petrie
Professor/Honorary Consultant (Institute of Cardiovascular & Medical Sciences)
Professor Mark Petrie worked as an interventional cardiologist before his professorship at University of Glasgow. His interests include revascularization in heart failure, diabetes and cardiovascular disease and cardio-oncology.